Source: IM Medical Publimas Digital s.l. The Ministry of Health and the Autonomous Communities have met to assess the suitability of new candidates to administer this […]
The pharmaceutical industry currently has about 600 new treatments against developing cardiovascular pathologies This Sunday, September 29, World Heart Day is celebrated Source: www.farmaindustria.es Cardiovascular diseases […]
Predictability, adequate taxation and imagination in the search for solutions, within the framework of a constant dialogue with the Administration, keys to ensure the advancement of […]
Impact on patient health, health system management and economic growth, among the most relevant effects The director of the Department of Pharmaceutical Studies, Pedro Luis Sánchez, […]
Each year 15,000 patients participate in clinical trials promoted by the pharmaceutical industry in Spain Source: www.farmaindustria.es Spain has become one of the reference countries in […]
Farmaindustria participates in the program ‘Es la Tarde de Dieter’, by EsRadio, in a debate on clinical research in Spain Source: www.farmaindustria.es Clinical trials, which are […]
Farmaindustria brings together in Madrid more than 120 experts to continue advancing in an area in which our country is already an international benchmark Source: www.farmaindustria.es […]
More than half of the clinical research with medicines is done in the early stages, the most complex Strengthen the participation of patients in all stages […]
Specifically, they collaborate in 48.5 percent of them according to Farmaindustria data Source: www.sanidadprivada.publicacionmedica.com Between 2004 and 2018, private health centers have participated in 1,431 clinical […]
Farmaindustria is working on a new online Guide for Early Phase Clinical Research Units for the benefit of the research community The University Hospital La Paz […]
The day ‘Controversies in patients with myeloma: candidate or not to haematopoietic transplantation and in relapse’, organized by the Jiménez Díaz Foundation and the San Carlos […]
After almost three years at the head of the Government, Theresa May has announced that she will present her resignation on June 7. Source: www.consalud.es This […]
Source: www.farmaindustria.es Each new drug that reaches patients has one behind or, in general, several successful clinical trials. The clinical trial, which in the vast majority […]
Source: www.redaccionmedica.com The clinical trials promoted by the pharmaceutical industry “are not only vital to develop new treatments for patients, but also play an important role […]
Source: www.farmaindustria.es Scientific research in general, and biomedical research in particular, are activities of general public interest, given the benefits they bring to society as a […]
It reveals the diversity of cancer and immune cells in the tumor ecosystem, with the aim of better selecting treatments. Source: immedicohospitalario.es Investigadores University of Zurich […]
Source: immedicohospitalario.es The regulatory ecosystem for the protection of intellectual property in Europe works. The set of laws, regulations and incentives developed by the European Union […]
Source: Redaccionmedica.com The Spanish Agency of Medicines and Health Products has presented its Strategic Plan 2019-2022 that includes a total of 11 measures that aim to […]
Source: Immedicohospitalario.es The carrying out of clinical trials in Spanish hospitals and research centers has very positive consequences for the agents involved. For the health system, […]
Source: Farmaindustria.es Have highly qualified, motivated and experienced professionals, have the ability to achieve patient participation and have processes digitized as electronic medical records. These are […]
Source: actasanitaria.com The pharmaceutical company Roche has announced the launch of a new platform for clinical trials that is designed with the needs of patients throughout […]
Source: actasanitaria.com On March 14, the 39th Symposium of the Spanish Association of Pharmaceutical Industry (AEFI) began in Barcelona, ??under the theme ‘Tracings and in contact […]
Source: actasanitaria.com During a debate at the 7th Forum of the Foundation for Excellence and Quality of Oncology (ECO) held in Madrid, the president of Farmaindustria, […]
Source: farmaindustria.es In less than three decades Spain has experienced an unprecedented advance in biomedical research, to be placed in the group of countries with better […]
Source: actasanitaria.com The Spanish Agency for Medicines and Healthcare Products (AEMPS) has informed about the possibility of requesting the temporary exemption from the obligation to carry […]
Source: diariomedico.com This Tuesday the institutional working group of the plan on T-CAR therapies in the SNS meets. At the entrance of the meeting, the Minister […]
Source: Farmaindustria.es “In this country we have a first-line healthcare system, well-trained health professionals, excellent research centers, committed patient organizations and pioneering legislation in Europe. Along […]
Source: Farmaindustria.es Representatives of the Spanish Agency of Medicines and Health Products, research teams, pharmaceutical industry and patient organizations agree on the opportunity and need to […]
Source: farmaindustria.es The commitment of the pharmaceutical industry to the research and development of treatments for rare diseases is indisputable and, as the data show, growing. […]
The Technological Platform for Innovative Medicines – whose Coordination Committee is made up of 10 representatives from the pharmaceutical industry and 10 representatives from public research […]
Farmaindustria welcomes the presentation by the Ministry of Health of the harmonised catalogue of genetic tests for the whole country. For this catalogue to become a […]
The US expert unpacked the data from his study on the relationship between pharmaceutical innovation and cancer mortality in Spain between 1999 and 2016 in a […]
Infectious diseases, neurological diseases, type 2 diabetes in children, oncology and cardiac disorders are just some of the areas that benefited from the innovation drive last […]
“We are the industrial area that invests the most in R&D, a productive and exporting engine”. larazon.es Developing and producing new medicines for society is both […]
The working group led by Farmaindustria holds a new meeting, with the participation of two new pharmaceutical companies. Farmaindustria.es The drive for clinical research in Primary […]
Of the €1.395 billion registered in 2022, 60% was devoted to clinical trial development. One out of every eight euros is already spent on basic and […]
Farmaindustria participates in the Medical Oncology, Haematology and Oncohaematology Pharmacy Congress ‘Building Bridges’, where data management in biomedical research was discussed. Farmaindustria.es “The proposed Regulation for […]
Farmaindustria’s CEO, Juan Yermo, participates in the conference ‘Towards a Comprehensive European Plan: Spain’s involvement with Rare Diseases’, organised by Feder in the Spanish Congress of […]
Farmaindustria presents the ‘Guide of good practice recommendations for the promotion of clinical research in Primary Care’, which will bring new treatment opportunities to patients in […]
The director of Farmaindustria’s Research Department participates in a round table on the regulation of this project held at the European Parliament Office in Madrid. “For […]